| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |